Higher Valency Pneumococcal Vaccines Need Stronger Local Evidence: Experts

Consultant paediatrician Dr Musa Mohd Nordin said vaccine selection should be based on the pneumococcal serotypes causing disease among Malaysian children, rather than the number of serotypes covered by a vaccine.

“If moving from PCV13 to PCV15 or PCV20 gives only a small extra benefit for a much higher price, keeping PCV13 could free up money for other important childhood vaccines in the national immunisation programme (NIP),” Dr Musa told CodeBlue when contacted.

…